RLY-105

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRLY-105
Drug Alias Namepotassium binder (IIypsa)potassium binder 1 (Relypsa)ILY-105RLY-105
ClassificationSmall molecules
Mechanisms of ActionPotassium metabolism modulators
TargetsUpdating
Therapy Area/IndicationsHyperkalemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesI.L.Y. Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesI.L.Y. SaRelypsa Inc
Active IndicationsN/A
Inactive IndicationsHyperkalemia

Other Information

ATC CodeN/A
Related LinksN/A